Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Hock

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Leukemia Research|July 1, 2014
Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMCB D Hock, S A Macpherson, L J Fernyhough, et al.
Bone Marrow Transplantation|November 20, 2002
Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantationB D Hock, L F Haring, A M Ebbett, et al.
European Journal of Immunology|July 1, 1995
Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory moleculeA D McLellan, G C Starling, L A Williams, et al.
British Journal of Haematology|April 14, 2006
Circulating levels and clinical significance of soluble CD86 in myeloma patientsB D Hock, M Drayson, W N Patton, et al.
Leukemia|May 3, 2002
Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patientsB D Hock, W N Patton, S Budhia, et al.
Blood|May 15, 1997
Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapyD B Fearnley, A D McLellan, S I Mannering, et al.
Immunobiology|April 30, 1998
Human dendritic cells express functional interleukin-7R V Sorg, A D McLellan, B D Hock, et al.
Internal Medicine Journal|December 17, 2009
CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population dataB D Hock, J L McKenzie, L McArthur, et al.
Leukemia Research|February 7, 2009
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemiaB D Hock, L J Fernyhough, S M Gough, et al.
Internal Medicine Journal|September 25, 2016
Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patientsB D Hock, N D McIntosh, J L McKenzie, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Leukemia Research|July 1, 2014
Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMCB D Hock, S A Macpherson, L J Fernyhough, et al.
Bone Marrow Transplantation|November 20, 2002
Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantationB D Hock, L F Haring, A M Ebbett, et al.
European Journal of Immunology|July 1, 1995
Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory moleculeA D McLellan, G C Starling, L A Williams, et al.
British Journal of Haematology|April 14, 2006
Circulating levels and clinical significance of soluble CD86 in myeloma patientsB D Hock, M Drayson, W N Patton, et al.
Leukemia|May 3, 2002
Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patientsB D Hock, W N Patton, S Budhia, et al.
Blood|May 15, 1997
Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapyD B Fearnley, A D McLellan, S I Mannering, et al.
Immunobiology|April 30, 1998
Human dendritic cells express functional interleukin-7R V Sorg, A D McLellan, B D Hock, et al.
Internal Medicine Journal|December 17, 2009
CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population dataB D Hock, J L McKenzie, L McArthur, et al.
Leukemia Research|February 7, 2009
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemiaB D Hock, L J Fernyhough, S M Gough, et al.
Internal Medicine Journal|September 25, 2016
Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patientsB D Hock, N D McIntosh, J L McKenzie, et al.
Pageof 3